Your browser doesn't support javascript.
loading
Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System
Annals of Laboratory Medicine ; : 569-577, 2018.
Article in English | WPRIM | ID: wpr-718325
ABSTRACT

BACKGROUND:

The increasing prevalence of drug-resistant tuberculosis (TB) infection represents a global public health emergency. We evaluated the usefulness of a newly developed multiplexed, bead-based bioassay (Quantamatrix Multiplexed Assay Platform [QMAP], QuantaMatrix, Seoul, Korea) to rapidly identify the Mycobacterium tuberculosis complex (MTBC) and detect rifampicin (RIF) and isoniazid (INH) resistance-associated mutations.

METHODS:

A total of 200 clinical isolates from respiratory samples were used. Phenotypic anti-TB drug susceptibility testing (DST) results were compared with those of the QMAP system, reverse blot hybridization (REBA) MTB-MDR assay, and gene sequencing analysis.

RESULTS:

Compared with the phenotypic DST results, the sensitivity and specificity of the QMAP system were 96.4% (106/110; 95% confidence interval [CI] 0.9072–0.9888) and 80.0% (72/90; 95% CI 0.7052–0.8705), respectively, for RIF resistance and 75.0% (108/144; 95% CI 0.6731–0.8139) and 96.4% (54/56; 95% CI 0.8718–0.9972), respectively, for INH resistance. The agreement rates between the QMAP system and REBA MTB-MDR assay for RIF and INH resistance detection were 97.6% (121/124; 95% CI 0.9282–0.9949) and 99.1% (109/110; 95% CI 0.9453–1.0000), respectively. Comparison between the QMAP system and gene sequencing analysis showed an overall agreement of 100% for RIF resistance (110/110; 95% CI 0.9711–1.0000) and INH resistance (124/124; 95% CI 0.9743–1.0000).

CONCLUSIONS:

The QMAP system may serve as a useful screening method for identifying and accurately discriminating MTBC from non-tuberculous mycobacteria, as well as determining RIF- and INH-resistant MTB strains.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Rifampin / Biological Assay / Mass Screening / Public Health / Prevalence / Sensitivity and Specificity / Tuberculosis, Multidrug-Resistant / Emergencies / Seoul / Isoniazid Type of study: Diagnostic study / Prevalence study / Prognostic study / Screening study Country/Region as subject: Asia Language: English Journal: Annals of Laboratory Medicine Year: 2018 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Rifampin / Biological Assay / Mass Screening / Public Health / Prevalence / Sensitivity and Specificity / Tuberculosis, Multidrug-Resistant / Emergencies / Seoul / Isoniazid Type of study: Diagnostic study / Prevalence study / Prognostic study / Screening study Country/Region as subject: Asia Language: English Journal: Annals of Laboratory Medicine Year: 2018 Type: Article